Webcast Alert: Aastrom Biosciences Announces Its Fourth Quarter and Fiscal Year End Investor Conference Call

Aastrom Biosciences (NASDAQ: ASTM) announces the
following Webcast:
-0-
*T
What:     Aastrom Biosciences Fourth Quarter and Fiscal Year End 
          FY2005 Investor Conference Call

When:     Thursday, September 8, 2005 @ 11:00 AM Eastern

Where:    http://www.vcall.com/EventPage.asp?ID=94806

How:      Live over the Internet -- Simply log on to the web at the 
          address above.  Interested parties should call toll-free 
          [phone], or from outside the U.S. [phone].

Contact:  Investor Relations Department, [phone] or 
          [e-mail] 
*T
   If you are unable to participate during the live webcast, the call
will be available for replay at
http://www.vcall.com/ClientPage.asp?ID=94806 or
http://www.investorcalendar.com/
   Aastrom Biosciences, Inc. (Nasdaq: ASTM) is developing
patient-specific products for the repair or regeneration of human
tissues, utilizing the Company's proprietary adult stem cell
technology. Aastrom's strategic position in the tissue regeneration
sector is enabled by its proprietary Tissue Repair Cells (TRCs), a mix
of bone marrow-derived adult stem and progenitor cells, and the
AastromReplicell(R) System, an industry-unique automated cell
production platform used to produce cells for clinical use. TRCs are
the core component of the products Aastrom is developing for severe
bone fractures, ischemic vascular disease, jaw reconstruction and
spine fusion, with Phase I/II level clinical trials active in the U.S.
and EU for some of these indications.
   For more information, visit Aastrom's website at www.aastrom.com.